These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 20647805)

  • 1. Biomarkers as end points in clinical trials of severe sepsis: a garden of forking paths.
    Salluh JI; Póvoa P
    Crit Care Med; 2010 Aug; 38(8):1749-51. PubMed ID: 20647805
    [No Abstract]   [Full Text] [Related]  

  • 2. Alternative outcome measures for pediatric clinical sepsis trials.
    Curley MA; Zimmerman JJ
    Pediatr Crit Care Med; 2005 May; 6(3 Suppl):S150-6. PubMed ID: 15857550
    [TBL] [Abstract][Full Text] [Related]  

  • 3. More evidence that timing matters in the treatment of patients with sepsis.
    Sevransky J
    Crit Care Med; 2008 Oct; 36(10):2932-3. PubMed ID: 18812795
    [No Abstract]   [Full Text] [Related]  

  • 4. Practice and perception--a nationwide survey of therapy habits in sepsis.
    Brunkhorst FM; Engel C; Ragaller M; Welte T; Rossaint R; Gerlach H; Mayer K; John S; Stuber F; Weiler N; Oppert M; Moerer O; Bogatsch H; Reinhart K; Loeffler M; Hartog C;
    Crit Care Med; 2008 Oct; 36(10):2719-25. PubMed ID: 18766100
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sepsis (mis) management: the hazards of a faith-based approach.
    Siegel MD
    Crit Care Med; 2008 Oct; 36(10):2929-30. PubMed ID: 18812793
    [No Abstract]   [Full Text] [Related]  

  • 6. Natriuretic peptides: biomarkers not predictive in the intensive care unit.
    Ginsberg F; Topalian S
    Crit Care Med; 2007 Apr; 35(4):1194-5. PubMed ID: 17413786
    [No Abstract]   [Full Text] [Related]  

  • 7. A randomized, double-blind, placebo-controlled trial of TAK-242 for the treatment of severe sepsis.
    Rice TW; Wheeler AP; Bernard GR; Vincent JL; Angus DC; Aikawa N; Demeyer I; Sainati S; Amlot N; Cao C; Ii M; Matsuda H; Mouri K; Cohen J
    Crit Care Med; 2010 Aug; 38(8):1685-94. PubMed ID: 20562702
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Is lactate the "Holy Grail" of biomarkers for sepsis prognosis?
    Jones AE; Puskarich MA
    Crit Care Med; 2009 May; 37(5):1812-3. PubMed ID: 19373056
    [No Abstract]   [Full Text] [Related]  

  • 9. [Clinical data on the use of selenase in sepsis].
    Lehmann Ch
    Dtsch Med Wochenschr; 2009 Dec; 134 Suppl 11():S411-3. PubMed ID: 19998233
    [No Abstract]   [Full Text] [Related]  

  • 10. Clinical evaluation committees: the time is right but is the timing right?
    Teplick R
    Crit Care Med; 2003 Sep; 31(9):2403-5. PubMed ID: 14501976
    [No Abstract]   [Full Text] [Related]  

  • 11. [Critical care research].
    Perner A; Heslet L; Larsson A; Toft P; Tønnesen EK
    Ugeskr Laeger; 2007 Feb; 169(8):677-9. PubMed ID: 17313911
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recombinant activated protein C in pediatric sepsis.
    Dalton HJ
    Pediatr Infect Dis J; 2003 Aug; 22(8):743-5. PubMed ID: 12913779
    [No Abstract]   [Full Text] [Related]  

  • 13. G-CSF and IL-8 for early diagnosis of sepsis in neonates and critically ill children - safety and cost effectiveness of a new laboratory prediction model: study protocol of a randomized controlled trial [ISRCTN91123847].
    Horisberger T; Harbarth S; Nadal D; Baenziger O; Fischer JE
    Crit Care; 2004 Dec; 8(6):R443-50. PubMed ID: 15566590
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adjunctive corticosteroid therapy in pediatric severe sepsis: many unsolved questions.
    Leclerc F; Botte A; Chêne G; Leteurtre S
    Pediatr Crit Care Med; 2011 Jan; 12(1):101-2. PubMed ID: 21209569
    [No Abstract]   [Full Text] [Related]  

  • 15. Reducing mortality in severe sepsis: the Surviving Sepsis Campaign.
    Townsend SR; Schorr C; Levy MM; Dellinger RP
    Clin Chest Med; 2008 Dec; 29(4):721-33, x. PubMed ID: 18954706
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prediction of sepsis after multiple trauma: does C-type natriuretic peptide do the trick?
    Suttner S; Boldt J
    Crit Care Med; 2010 Jan; 38(1):323-4. PubMed ID: 20023484
    [No Abstract]   [Full Text] [Related]  

  • 17. Diabetes does not alter mortality or hemostatic and inflammatory responses in patients with severe sepsis.
    Stegenga ME; Vincent JL; Vail GM; Xie J; Haney DJ; Williams MD; Bernard GR; van der Poll T
    Crit Care Med; 2010 Feb; 38(2):539-45. PubMed ID: 19851093
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A marker for posttraumatic-sepsis: searching for the Holy Grail around intensive care units.
    Vega VL
    Crit Care Med; 2009 May; 37(5):1806-7. PubMed ID: 19373052
    [No Abstract]   [Full Text] [Related]  

  • 19. Tumor necrosis factor alpha and interleukin 6 in infants with sepsis.
    Makhija P; Yadav S; Thakur A
    Indian Pediatr; 2005 Oct; 42(10):1024-8. PubMed ID: 16269840
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High C5a levels are associated with increased mortality in sepsis patients--no enhancing effect by actin-free Gc-globulin.
    Gressner OA; Koch A; Sanson E; Trautwein C; Tacke F
    Clin Biochem; 2008 Aug; 41(12):974-80. PubMed ID: 18538666
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.